Withings has partnered with Abbott's Lingo CGM to bring glucose monitoring to 15 million users starting Q1 2026 for metabolic ...
Jake Leach, Dexcom CEO, joins 'Closing Bell Overtime' to talk its 2026 outlook, the impact of GLP-1s, new devices and more.
Dexcom’s new CEO is eyeing growth in the international market as a key strategy for 2026, fresh off the back of the company ...
In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback